Zanamivir
Links shared publicly online about this topic
FDA Alert: Relenza (zanamivir) Inhalation Powder
drugs.com — “FDA Alert: Relenza (zanamivir) Inhalation Powder” View full resource at drugs.com
Most Recently Shared on October 9, 2009 at 10:18 pm By:
FDA Alert - GSK and FDA Warn Against Nebulization of Relenza (zanamivir) Inhalation Powder - http://bit.ly/2f9w7Q
Simcere Pharmaceutical Group subsidiary receives Chinese SFDA approval for Zanamivir
news-medical.net — “Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration ("SFDA") to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant used in the prevention and treatment of I” View full resource at news-medical.net
Most Recently Shared on February 11, 2010 at 1:32 pm By:
H1N1 Swine Flu News: Simcere Pharmaceutical Group subsidiary receives Chinese SFDA approval for Zanamivir: Simce... http://twurl.nl/l2y5nw
GlaxoSmithKline commences Phase III study of intravenous zanamivir for hospitalised patients with influenza
us.gsk.com — “GlaxoSmithKline commences Phase III study of intravenous zanamivir for hospitalised patients with influenza” View full resource at us.gsk.com
Most Recently Shared on January 19, 2011 at 2:42 pm By:
eyeonfda Pharma and Health Lawyer
GSK commences Phase III study of intravenous zanamivir for hospitalized patients with influenza http://ow.ly/3Gsjp
NEJM -- Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza
content.nejm.org — “Correspondence from The New England Journal of Medicine -- Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza” View full resource at content.nejm.org
Most Recently Shared on December 23, 2009 at 10:23 pm By:
St. Jude group reports on one case of oseltamivir-resistant H1N1 that was successfully treated with IV zanamivir. http://bit.ly/54Tfbu
CIDRAP >> FLU NEWS SCAN: Australia's flu surge, IV zanamivir in H1N1 patients
cidrap.umn.edu — “CIDRAP >> FLU NEWS SCAN: Australia's flu surge, IV zanamivir in H1N1 patients” View full resource at cidrap.umn.edu
Most Recently Shared on August 17, 2011 at 1:23 am By:
FLU NEWS SCAN: Australia's flu surge, IV zanamivir in H1N1 patients: Australia sees continued high flu levels Fl... http://t.co/4mR6eAD
Medical News: ACIP: Zanamivir Best for All Flu, Including New H1N1 - in Meeting Coverage, ACIP from MedPage Today
medpagetoday.com — “ATLANTA -- Zanamivir (Relenza) should be the preferred treatment for patients with influenza-like illness, whether infection is caused by a seasonal virus or the pandemic H1N1 virus, an advisory commi” View full resource at medpagetoday.com
Most Recently Shared on June 29, 2009 at 5:55 pm By:
CLINICAL TRIALS• ACIP: Zanamivir Best for All Flu, Including New H1N1 (CME/CE) http://tinyurl.com/ln5res
Infectious Disease Article | Influenza, Human
mdlinx.com — “Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic review” View full resource at mdlinx.com
Most Recently Shared on November 22, 2010 at 11:07 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic review: Journal of Infection http://bit.ly/dciScf #ID
Tamiflu And Relenza Should Have Psychiatric Side Effects Warning, Say Regulators
medicalnewstoday.com — “After receiving reports of patients experiencing delirium, psychosis and hallucinations, US FDA staff recommend that flu drugs, Tamiflu and Relenza should carry warnings about possible side-effect” View full resource at medicalnewstoday.com
Most Recently Shared on April 28, 2009 at 2:19 am By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
RT @larrybrauner: Never simple! "Tamiflu And Relenza Should Have Psychiatric Side Effects Warning, Say Regulators" http://budurl.com/j93s
Drug and vaccine makers on standby over swine flu | Reuters
reuters.com — “* Roche's Tamiflu and Glaxo's Relenza drugs effective * Roche says ready to deploy stockpile of 3 mln packages * Vaccine makers liaising with WHO on response By Ben Hirschler and Sam Cage LONDON/ZURICH,” View full resource at reuters.com
Most Recently Shared on April 26, 2009 at 3:58 pm By:
HealthMap.org Health Organization
Drug and Vaccine Makers on Standby: http://www.reuters.com/article/rbssHealthcareNews/idUSLQ58864920090426
Infectious Disease Article | Influenza A virus
mdlinx.com — “Effect of Half-Life on the Pharmacodynamic Index of Zanamivir against Influenza Virus Delineated by a Mathematical Model” View full resource at mdlinx.com
Most Recently Shared on March 31, 2011 at 2:55 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of Half-Life on the Pharmacodynamic Index of Zanamivir against Influenza Virus Delineated by a Mathem... http://bit.ly/gIalSe #ID
Medical News: Popular Flu Drugs Have Modest Effect - in Pulmonology, Flu & URI from MedPage Today
medpagetoday.com — “In healthy adults with seasonal flu, the antiviral drugs oseltamivir (Tamiflu) and zanamivir (Relenza) reduce the duration of symptoms by about half a day, British researchers said.” View full resource at medpagetoday.com
Most Recently Shared on August 8, 2009 at 5:32 am By:
Popular Flu Drugs Have Modest Effect (CME/CE) http://ow.ly/15Kh28
Pediatrics Medical News about Influenza A Virus, H1N1 Subtype
mdlinx.com — “Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus” View full resource at mdlinx.com
Most Recently Shared on May 1, 2010 at 2:06 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed... http://bit.ly/bEL0r8 #peds
GSK tests intravenous flu drug vs Roche's Tamiflu
health.yahoo.net — “GlaxoSmithKline has started a pivotal study testing intravenous zanamivir against Roche's best-selling pill Tamiflu as a treatment for patients hospitalised with influenza, it said on Wednesday.” View full resource at health.yahoo.net
Most Recently Shared on January 19, 2011 at 10:58 am By:
Jennifer Ann Grisso Nurse and Active Health Library
GSK tests intravenous flu drug vs Roche's Tamiflu: GlaxoSmithKline has started a pivotal study testing intraveno... http://bit.ly/eM99C3
GSK tests intravenous flu drug vs Roche's Tamiflu | Reuters
reuters.com — “LONDON (Reuters) - GlaxoSmithKline has started a pivotal study testing intravenous zanamivir against Roche's best-selling pill Tamiflu as a treatment for patients hospitalised with influenza, it said on” View full resource at reuters.com
Most Recently Shared on January 19, 2011 at 11:24 am By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
GSK tests intravenous flu drug vs Roche's Tamiflu http://ow.ly/1aVOOW
GSK tests intravenous flu drug vs Roche's Tamiflu
health.yahoo.net — “GlaxoSmithKline has started a pivotal study testing intravenous zanamivir against Roche's best-selling pill Tamiflu as a treatment for patients hospitalised with influenza, it said on Wednesday.” View full resource at health.yahoo.net
Most Recently Shared on January 19, 2011 at 10:53 am By:
Jane Anderson Healthy Eating Advisor
GSK tests intravenous flu drug vs Roche's Tamiflu http://bit.ly/hULdbR
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
News-Medical.Net
Influenza A virus subtype H1N1
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
